[Information Sharing] Weekly Update on International Animal Disease Outbreaks (November 18–22)

1. Twenty-eight outbreaks of African swine fever in wild pigs have been reported in Germany. 
 

On November 18 and 20, Germany reported 28 outbreaks of African swine fever in wild boar in two regions, including Brandenburg, resulting in the infection and death of 28 wild boar.

2. Twenty-two African swine fever outbreaks in wild pigs reported in Hungary

On November 19, Hungary reported 22 cases of African swine fever in wild boars across three regions, including Pest County, resulting in the infection and death of 22 animals.

3. Three Outbreaks of African Swine Fever in Wild Boars Reported in Italy

On November 20, Italy reported three outbreaks of African swine fever in wild pigs in Lombardy and another region, resulting in the death of three infected wild pigs.

4. Twenty-six outbreaks of African swine fever in domestic pigs have occurred in Serbia.

On November 20, Serbia reported 26 outbreaks of African swine fever in domestic pigs across five districts, including Pirot District, resulting in 62 infected pigs, 24 deaths, and the culling of 604 pigs.

5. Poland Reports 107 Outbreaks of African Swine Fever in Wild Boars

On November 20, Poland reported 107 outbreaks of African swine fever in wild boars across five regions, including the Pomeranian Voivodeship, resulting in the infection and death of 146 wild boars.

6. One outbreak of African swine fever in domestic pigs reported in Ukraine

On November 21, Ukraine reported an outbreak of African swine fever in domestic pigs in Odessa Oblast, resulting in the infection and death of 20 pigs.

7. Six Outbreaks of African Swine Fever in Domestic Pigs Reported in Romania

On November 22, Romania reported six outbreaks of African swine fever in domestic pigs in four counties, including Călărași County, resulting in 4,878 infected pigs, 310 deaths, and the culling of 28,000 pigs.

1. Sixty-one outbreaks of H5N1 highly pathogenic avian influenza in dairy cattle have occurred in the United States.

On November 18, the United States reported 61 outbreaks of highly pathogenic H5N1 avian influenza among mammals at several dairy farms in California, with multiple cows infected.

2. Ten outbreaks of H5N1 highly pathogenic avian influenza in poultry and one in wild birds have been reported in Canada.

On November 18 and 22, Canada reported 10 outbreaks of H5N1 highly pathogenic avian influenza in poultry and 1 outbreak in wild birds in British Columbia and another region, resulting in the infection and death of 19,000 poultry, the culling of 494,000 poultry, the infection and death of 36 free-range poultry, and the culling of 5 free-range poultry.

3. Two outbreaks of H5N1 highly pathogenic avian influenza in poultry and 17 outbreaks in wild birds have been reported in Japan.

On November 18 and 22, Japan reported two outbreaks of highly pathogenic H5N1 avian influenza in poultry and 17 outbreaks in wild birds across six locations, including Hokkaido Prefecture. A total of 187 poultry were infected and died, 59,000 were culled, and 20 wild birds were infected and died.

4. One outbreak of H5N1 highly pathogenic avian influenza in poultry and one in wild birds have been reported in Hungary.

On November 19 and 21, Hungary reported one outbreak of highly pathogenic H5N1 avian influenza in poultry and one in wild birds in two locations, including Csongrád County, resulting in the death of multiple infected poultry and two infected wild birds.

5. Two Outbreaks of Highly Pathogenic H5N5 Avian Influenza in Wild Birds Reported in Iceland

On November 19 and 22, Iceland reported two outbreaks of highly pathogenic H5N5 avian influenza in wild birds in the capital region and another area, resulting in the death of two infected wild birds.

6. One outbreak of H5N1 highly pathogenic avian influenza in poultry and four outbreaks in wild birds have been reported in the United Kingdom.

On November 19 and 22, the United Kingdom reported one outbreak of highly pathogenic H5N1 avian influenza in poultry and four outbreaks in wild birds in England and two other regions, with 28 poultry infected, 15 dead, and 6 wild birds infected and dead.

7. Five outbreaks of H5N1 highly pathogenic avian influenza in wild birds and two in poultry have been reported in Poland.

On November 19, 20, 21, and 22, Poland reported five outbreaks of highly pathogenic H5N1 avian influenza in wild birds and two in poultry in three regions, including the Greater Poland Voivodeship. A total of 124 wild and free-range poultry were infected and died; 323,000 poultry were infected, with 1,298 deaths; and 329,000 birds were culled.

8. One outbreak of H5N1 highly pathogenic avian influenza in poultry and one in wild birds have been reported in Turkey.

On November 19, Turkey reported one outbreak of highly pathogenic H5N1 avian influenza in poultry and one in wild birds in Konya Province and another location. A total of 610 poultry were infected, 570 died, 95,000 were culled, 15 free-range poultry were infected and died, and 1,848 were culled.

9. One outbreak of H5 subtype highly pathogenic avian influenza in poultry has occurred in the Netherlands.

On November 19, the Netherlands reported an outbreak of highly pathogenic H5 subtype avian influenza in poultry in Gelderland Province, with 227 infected birds, 50 deaths, and 23,000 birds culled.

10. One outbreak of highly pathogenic H5N1 avian influenza in poultry and one in wild birds have been reported in Germany.

On November 20 and 22, Germany reported one outbreak of highly pathogenic H5N1 avian influenza in poultry and one in wild birds in North Rhine-Westphalia and another region, resulting in the death of 50 poultry and 3 wild birds.

11. Four outbreaks of H5N1 highly pathogenic avian influenza in wild birds and two in poultry have been reported in Italy.

On November 20, Italy reported four outbreaks of highly pathogenic H5N1 avian influenza in wild birds and two in poultry in two regions, including Friuli-Venezia Giulia. Four wild birds were infected and died, 51 poultry were infected and died, and 1,024 poultry were culled.

12. Two Outbreaks of H5N1 Subtype Highly Pathogenic Avian Influenza in Poultry Reported in South Korea

On November 20, South Korea reported two outbreaks of highly pathogenic H5N1 avian influenza in poultry in Incheon City and North Chungcheong Province, resulting in 340 infected birds, 220 deaths, and the culling of 40,000 birds.

13. Three Outbreaks of Highly Pathogenic H5N1 Avian Influenza in Wild Birds Reported in Spain

On November 20, Spain reported three outbreaks of highly pathogenic H5N1 avian influenza in wild birds in Galicia, resulting in the death of three infected birds.

14. Six Outbreaks of H5N1 Highly Pathogenic Avian Influenza in Wild Birds Reported in Slovenia

On November 22, Slovenia reported six outbreaks of highly pathogenic H5N1 avian influenza in wild birds in three areas, including the Drava Statistical Region, resulting in the infection and death of 22 wild birds.

15. One outbreak of highly pathogenic H5N1 avian influenza in wild birds has been reported in France.

On November 22, France reported an outbreak of highly pathogenic H5N1 avian influenza in wild birds in the Hautes-Pyrénées department of the Occitanie region, resulting in the death of one infected wild bird.

16. Three Outbreaks of Highly Pathogenic H5N5 Avian Influenza in Wild Birds Reported in the United Kingdom

On November 22, the United Kingdom reported three outbreaks of highly pathogenic H5N5 avian influenza in wild birds in Scotland and two other locations, resulting in the death of five infected wild birds.

17. Eleven outbreaks of H5N1 highly pathogenic avian influenza in poultry and five in wild birds have been reported in the United States.

On November 22, the United States reported 11 outbreaks of highly pathogenic H5N1 avian influenza in poultry and 5 in wild birds across California and another jurisdiction, resulting in the culling of 3.114 million poultry, the death of 84 free-range poultry due to infection, and the culling of 148 additional birds.

1. One outbreak of O-type foot-and-mouth disease has occurred in Palestine.

On November 20, Palestine reported an outbreak of O-type foot-and-mouth disease in the West Bank, affecting 130 sheep and resulting in 45 deaths.

2. Six Outbreaks of SAT2 Foot-and-Mouth Disease in Algeria

On November 22, Algeria reported six outbreaks of SAT2 foot-and-mouth disease in four locations, including Bejaia Province, affecting 32 cattle.

3. Forty Outbreaks of Sheep Pox in Greece

On November 18, 19, and 21, Greece reported 40 outbreaks of sheep pox in two regions—Macedonia and Thrace—resulting in infection of 423 sheep and goats and the death of 159.

4. Seven Outbreaks of Bluetongue Serotype 8 in Greece

On November 18, Greece reported seven outbreaks of Bluetongue serotype 8 in the regions of Macedonia and Thrace, affecting 463 sheep and resulting in 24 deaths.

5. Fourteen Outbreaks of Bluetongue Serotype 3 Reported in the Czech Republic

On November 18, the Czech Republic reported 14 outbreaks of Bluetongue virus serotype 3 in four regions, including the Liberec Region, with multiple cattle infected.

6. Three Outbreaks of Bluetongue Serotype 3 in France

On November 18, France reported three outbreaks of Bluetongue serotype 3 in three locations, including the Southern Corsica department in the Corsica region, affecting two cattle and one sheep.

7. One West Nile fever outbreak reported in France

On November 18, France reported an outbreak of West Nile fever in the Bouches-du-Rhône department of the Provence-Alpes-Côte d’Azur region, with one horse infected.

8. One West Nile fever outbreak in Guadeloupe

On November 18, Guadeloupe (French overseas department) reported an outbreak of West Nile fever in the Pointe-à-Pitre administrative district, with one wild bird infected and subsequently dying.

9. Forty-nine outbreaks of Bluetongue Virus Serotype 3 have occurred in Denmark.

On November 18, the Czech Republic reported 49 outbreaks of Bluetongue serotype 3 in ten locations, including the city of Šol, affecting 200 cattle and resulting in three deaths.

10. Two Outbreaks of Bluetongue Virus Serotype 3 in Norway

On November 19 and 22, Norway reported two outbreaks of Bluetongue serotype 3 in Agder County, affecting two cattle.

11. Four Outbreaks of Small Hive Beetle Infestation Reported in Italy

On November 20, Italy reported four outbreaks of small hive beetle infestation in the Thessaly region, affecting nine beehives.

12. Two West Nile Fever Outbreaks in Germany

On November 20 and 22, Germany reported two West Nile virus outbreaks in Berlin and another region, involving one infected horse and one wild bird that died after infection.

13. Three Outbreaks of Lumpy Skin Disease in South Korea

On November 20, South Korea reported three outbreaks of lumpy skin disease in three locations, including Jeollanam-do Province, resulting in the culling of 68 infected cattle.

14. Two Outbreaks of Bluetongue Virus Serotype 3 in Germany

On November 21, Germany reported two outbreaks of Bluetongue disease type 3 in the state of Berlin, affecting one cow and one sheep.

15. Twelve Outbreaks of Lumpy Skin Disease in Algeria

On November 22, Algeria reported 12 outbreaks of lumpy skin disease in seven regions, including Algiers Province, affecting 41 cattle and resulting in 8 deaths.

16. One outbreak of sheep pox reported in Bulgaria

On November 22, Bulgaria reported an outbreak of sheep pox in Haskovo Province, resulting in the death of one infected sheep and the culling of 243 others.

17. Three Outbreaks of Newcastle Disease in Poland

On November 22, Poland reported three outbreaks of Newcastle disease in Podlaskie Voivodeship, resulting in infection of 227,000 poultry, 29,000 deaths, and the culling of 197,000 birds.

18. Five Outbreaks of Bluetongue Virus Serotype 3 in the United Kingdom

On November 22, the United Kingdom reported five outbreaks of Bluetongue serotype 3 in Gloucestershire, with six cattle infected and one culled.

When looking for animal disease testing reagents, choose the Weiboxin brand.

Be aware of Weiboxin Bio All products of!

Official consultation phone numbers: 020-66377266 / 135 3988 6748, Ms. Dai

Guangzhou Weiboxin Biotechnology Co., Ltd. is located in the national-level innovation park—Guangzhou Science City—and is a provincial-level “Little Giant” high-tech enterprise specializing in the forward R&D, manufacturing, sales, and technical services of diagnostic reagents for animal epidemics. The company is also recognized as a “Contract-Honoring and Credit-Keeping Enterprise” by Guangdong Province and a provincial demonstration unit for intellectual property; it serves as an industry–university–research base for Guangdong Food and Drug Vocational College and as an executive director unit of the Veterinary Diagnostic and Biological Products Committee of the Guangdong Society of Animal Husbandry and Veterinary Medicine. Furthermore, it has been designated as an innovative, high-potential enterprise by multiple research institutes, including the Entrepreneurship College of Jinan University in Guangdong Province, and has been awarded the titles of “Specialized, Refined, Distinctive, and Innovative” enterprise at both municipal and provincial levels. The company has received the “Most Investment-Valuable Enterprise” award and the annual title of “ASF and Swine Disease Testing Service Provider.” It has also obtained approval numbers from the Ministry of Agriculture and Rural Affairs for veterinary drug products: Veterinary Drug Registration No. 191438923 (Fluorescent PCR Test Kit for African Swine Fever Virus), Veterinary Drug Registration No. 191438213 (ELISA Antibody Test Kit for Porcine Reproductive and Respiratory Syndrome Virus), and Veterinary Drug Registration No. 191438875 (Blocking ELISA Antibody Test Kit for Classical Swine Fever Virus). In the 11th China Innovation and Entrepreneurship Competition, the company won the Excellence Award in the Growth Category of the Biopharmaceutical Industry; in the Nanotechnology Industry Technology Competition under the same event, it secured the Provincial Second Prize in the Growth Category; and in the National Finals of the Nanotechnology Industry Technology Innovation Special Competition within the China Innovation and Entrepreneurship Competition, it was awarded the National Third Prize in the Growth Category. Additionally, the company has consecutively received the A-Level Tax Credit Honor Certificate, the Four-Star Trademark Brand Certification, and the Two-Integration Management System Assessment Certificate each year. It has also obtained ISO 9001 International Quality Management System Certification, ISO 14001 International Environmental Management System Certification, and GMP certification from the Ministry of Agriculture. Since its establishment, the company has been granted a total of 24 patents, including 5 invention patents, 15 utility model patents, and 4 design patents, as well as more than ten trademarks.

The company boasts robust technical capabilities and a team of world-class professionals, including dozens of masters, doctors, and returnees who studied abroad, as well as numerous senior-title technical experts. Currently, the company’s primary focus is on the research and development of molecular diagnostic reagents. Its core R&D team has developed more than 600 products spanning molecular diagnostics and immunoassays, including public-health–oriented fluorescent PCR test kits, animal disease–control–oriented fluorescent PCR test kits, clinical and research–grade fluorescent quantitative PCR kits, and transgenic identification test kits (ZL2006). The company has also established a nationwide distribution network covering more than ten major cities, such as Beijing, Shanghai, Hangzhou, Nanjing, Xi’an, Chongqing, Lanzhou, Zhengzhou, and Qingdao.

Looking ahead, Weiboxin will remain steadfast in its commitment to continuously enhance product quality and service standards. Leveraging a rapid and efficient research platform and abundant biomedical resources, we will conduct extensive and in-depth R&D and scientific research in the biomedical field, thereby contributing to human health and advancing life sciences. Quality is our lifeline, and innovation is our soul; we will unwaveringly uphold this philosophy as we strive to become the premier supplier of rapid diagnostic reagents and instruments.